Epigenetic changes are changes in gene expression by regulating gene transcription and translation without changing the nucleotide sequence of the genome. Although the genome itself changes during the occurrence and development of most malignant tumors, recent studies have found that epigenetic changes also play an important role in the occurrence and development of tumors. Epigenetic modification mainly includes DNA methylation, histone modification and miRNA regulation. This review focuses on the role and mechanism of epigenetic modification in the occurrence, metastasis and invasion of hepatocellular carcinoma (HCC), and summarizes the latest methods for the treatment of HCC by restoring dysregulated epigenetic modification. It provides a theoretical basis for revealing the pathogenesis of liver cancer and developing new methods of diagnosis and treatment.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
Vogel, A., Meyer, T., Sapisochin, G., Salem, R. and Saborowski, A. (2022) Hepatocellular Carcinoma. The Lancet, 400, 1345-1362. https://doi.org/10.1016/S0140-6736(22)01200-4
Yang, J.D., Hainaut, P., Gores, G.J., Amadou, A., Plymoth, A. and Roberts, L.R. (2019) A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management. Nature Reviews Gastroenterology & Hepatology, 16, 589-604. https://doi.org/10.1038/s41575-019-0186-y
Kulik, L. and El-Serag, H.B. (2019) Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology, 156, 477-491. https://doi.org/10.1053/j.gastro.2018.08.065
Waddington, C. (1939) Preliminary Notes on the Development of the Wings in Normal and Mutant Strains of Drosophila. Proceedings of the National Academy of Sciences of the United States of America, 25, 299-307. https://doi.org/10.1073/pnas.25.7.299
Holliday, R. (1987) The Inheritance of Epigenetic Defects. Science, 238, 163-170. https://doi.org/10.1126/science.3310230
Wolffe, A.P. and Matzke, M.A. (1999) Epigenetics: Regulation through Repression. Science, 286, 481-486. https://doi.org/10.1126/science.286.5439.481
Bird, A. (2002) DNA Methylation Patterns and Epigenetic Memory. Genes & Development, 16, 6-2l. https://doi.org/10.1101/gad.947102
Egger, G, Liang, G, Aparicio, A., et al. (2004) Epigenetics in Human Disease and Prospects for Epigenetic Therapy. Nature, 429, 457-463. https://doi.org/10.1038/nature02625
Xiang, W.Q., Feng, W.F., Ke, W., et al. (2011) Hepatitis B Virus X Protein Stimulates IL-6 Expression in Hepatocytes via a MyD88 Dependent Pathway. Journal of Hepatology, 54, 26-33. https://doi.org/10.1016/j.jhep.2010.08.006
Esteller, M., Corn, P.G., Baylin, S.B., et al. (2001) A Gene Hypermethylation Profile of Human Cancel. Cancer Research, 61, 3225-3229.
Tannapfel, A. and Wittekind, C. (2002) Genes Involved in Hepatocellular Carcinoma: Deregulation in Cell Cycling and Apoptosis. Virchows Archiv, 440, 345-352. https://doi.org/10.1007/s00428-002-0617-x
Kaneto, H., Sasaki, S., Yamamoto, H., et al. (2001) Detection of Hypermethylation of the P16 (INK4A) Gene Promoter in Chronic Hepatitis and Cirrhosis Associated with Hepatitis B or C Virus. Gut, 48, 372-377. https://doi.org/10.1136/gut.48.3.372
Tannapfel, A., Busse, C., Weinans, L., et al. (2001) INK4a-ARF Alterations and P53 Mutations in Hepatoceilular Carcinomas. Oncogene, 20, 7104-7109. https://doi.org/10.1038/sj.onc.1204902
Sharpless, N.E. and DePinho, R.A. (1999) The INK4A/ARF Locus and Its Two Gene Products. Current Opinion in Genetics & Development, 9, 22-30. https://doi.org/10.1016/S0959-437X(99)80004-5
Medema Scaffidi, C., Kischkel, F.C., et al. (1997) FLICE Is Activated by Association with the CD95 Death-Inducing Signaling Complex (DISC). The EMBO Journal, 16, 2794-2804. https://doi.org/10.1093/emboj/16.10.2794
Teitz, L., et al. (2000) Caspase 8 Is Deleted or Silenced Preferentially in Childhood Neuroblastomas with Amplification of MYCN. Nature Medicine, 6, 529-535. https://doi.org/10.1038/75007
Yu, J., Ni, M., Xu, J., et al. (2002) Methylation Profiling of Twenty Promoter-CpG Islands of Genes Which May Contribute to Hepatocellular Carcinogenesis. BMC Cancer, 2, Article No. 29. https://doi.org/10.1186/1471-2407-2-29
Kubo, T., Yamamoto, J., Shikauchi, Y., et al. (2004) Apoptotic Speck Proteinlike, a Highly Homologous Protein to Apoptotic Speck Protein in the Pyrin Domain, Is Silenced by DNA Methylation and Induces Apoptosis in Human Hepatocellular Carcinoma. Cancer Research, 64, 5172-5177. https://doi.org/10.1158/0008-5472.CAN-03-3314
Zhang, C., Li, H., Zhou, G., et al. (2007) Transcriptional Silencing of the TMSl/ASC Tumour Suppressor Gene by an Epigenetic Mechanism in Hepatocellular Carcinoma Cells. The Journal of Pathology, 212, 134-142. https://doi.org/10.1002/path.2173
Matsumura, T’Makino, R. and Mitamura, K. (2001) Frequent Down-Regulation of E-Cadhefin by Genetic and Epigenetic Changes in the Malignant Progression of Hepatocellular Carcinomas. Clinical Cancer Research, 7, 594·599.
Wei, Y., Van Nhieu, J.T., Prigent, S., et al. (2002) Altered Expression of Ecadherin in Hepatocellular Carcinoma: Correlations with Genetic Alterations, Beta Catenin Expression, and Clinical Features. Hepatology, 36, 692-701. https://doi.org/10.1053/jhep.2002.35342
Kim, Y.I., Giuliano, A., Hatch, K.D., et al. (1994) Global DNA Hypomethylation Increases Progressively in Cervical Dysplasia and Carcinoma. Cancer, 74, 893-899. https://doi.org/10.1002/1097-0142(19940801)74:3 3.0.CO;2-B
Lin, C.H., Hsieh, S.Y., Sheen, I.S., et al. (2001) Genome-Wide Hypomethylmion in Hepatocellular Carcinogenesis. Cancer Research, 61, 4238-4243.
Gibney, E.R. and Nolan, C.M. (2010) Epigenetics and Gene Expression. Heredity (Edinb), 105, 4-13. https://doi.org/10.1038/hdy.2010.54
Berger, S.L., Kouzarides, L, Shiekhattar, R., et al. (2009) An Operational Definition of Epigenetics. Genes & Development, 23, 781-783. https://doi.org/10.1101/gad.1787609
Martin, C. and Zhang, Y. (2005) The Diverse Functions of Historic Lysine Methylation. Nature Reviews Molecular Cell Biology, 6, 838-849. https://doi.org/10.1038/nrm1761
Whetstine, J.R., Nottke, A., Lan, F., et al. (2006) Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases. Cell, 125, 467-481. https://doi.org/10.1016/j.cell.2006.03.028
Ada, Y., Fang, J., Erdjument-Bromage, H., et al. (2006) Histone Demethylation by a Family of JmjC Domain-Containing Proteins. Nature, 439, 811-816. https://doi.org/10.1038/nature04433
Hamamoto, R., Furukawa, Y., Morita, M., et al. (2004) SMYD3 Encodes a Histone Methyltransferase Involved in the Proliferation of Cancer Cells. Nature Cell Biology, 6, 731-740. https://doi.org/10.1038/ncb1151
Fang, W., Piao, Z., Simon, D., et al. (2000) Mapping of a Minimal Deleted Region in Human Hepatocellular Carcinoma to 1p36.13-p36.23 and Mutational Analysis of the RIZ (PRDM2) Gene Localized to the Region. Genes Chromosomes Cancer, 28, 269-275. https://doi.org/10.1002/1098-2264(200007)28:3 3.3.CO;2-B
Magerl, C., Ellinger, J., Braunschweig, L., et al. (2010) H3K4 Dimethylation in Hepatocellular Carcinoma Is Rare Compared with Other Hepatobiliary and Gastrointestinal Carcinomas and Correlates with Expression of the Methylase Ash2 and the Demethylase LSD1. Human Pathology, 41, 181-189. https://doi.org/10.1016/j.humpath.2009.08.007
Osawa, L., Muramatsu, M., Wang, F., et al. (2011) Increased Expression of Histone Demethylase JHDM1D under Nutrient Starvation Suppresses Tumor Growth via Down-Regulating Angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 108, 20725-20729. https://doi.org/10.1073/pnas.1108462109
Greiner, D., Bonaldi, T., Eskeland, R., et al. (2005) Identification of a Specific Inhibitor of the Histone Methyltransferase SU(VAR)3-9. Nature Chemical Biology, 1, 143-145. https://doi.org/10.1038/nchembio721
Tan, J., Yang, X., Zhuang, L., et al. (2007) Pharmacologic Disruption of Polycomb Repressive Complex 2-Mediated Gene Repression Selectively Induces Apoptosis in Cancer Cells. Genes & Development, 21, 1050-1063. https://doi.org/10.1101/gad.1524107
Chiba, T., Suzuki, E., Negishi, M., et al. (2012) 3-Deazaneplanocin A Is a Promising Therapeutic Agent for the Eradication of Tumor-Initiating Hepatocellular Carcinoma Cells. International Journal of Cancer, 130, 2557-2567. https://doi.org/10.1002/ijc.26264
Yang, X.J. (2004) The Diverse Superfamily of Lysine Acetyltransferases and Their Roles in Leukemia and Other Diseases. Nucleic Acids Research, 32, 959-976. https://doi.org/10.1093/nar/gkh252
Smith, E.M., Boyd, K. and Davies, F.E. (2010) The Potential Role of Epigenctic Therapy in Multiple Myeloma. British Journal of Haematology, 148, 702-713. https://doi.org/10.1111/j.1365-2141.2009.07976.x
Lei, W., Zhang, L., Pan, X., et al. (2010) Histone Deacetylase 1 Is Required for Transforming Growth Factor-β1-Induced Epithelial-Mesenchymal Transition. The International Journal of Biochemistry & Cell Biology, 42, 1489-1497. https://doi.org/10.1016/j.biocel.2010.05.006
Bhaskara, S., Knutson, S.K., Jiang, G., et al. (2010) Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability. Cancer Cell, 18, 436-447. https://doi.org/10.1016/j.ccr.2010.10.022
Choi, H.N., Bae, J.S., Jamiyandorj, U., et al. (2011) Expression and Role of SIRT1 in Hepatocellular Carcinoma. Oncology Reports, 26, 503-510.
Chen, J., Zhang, B., Wong, N., et al. (2011) Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas Where It Is Essential for Telomere Maintenance and Tumor Cell Growth. Cancer Research, 71, 4138-4149. https://doi.org/10.1158/0008-5472.CAN-10-4274
Mann, B.S., Johnson, J.R., Cohen, M.H., et al. (2007) FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma. Oncologist, 12, 1247-1252. https://doi.org/10.1634/theoncologist.12-10-1247
Carew, J.S., Giles, F.J. and Nawrocki, S.T. (2008) Histone Deacetylase Inhibitors: Mechanisms of Cell Death and Promise in Combination Cancer Therapy. Cancer Letters, 269, 7-17. https://doi.org/10.1016/j.canlet.2008.03.037
Carlisi, D., Vassallo, B., Laudcella, M., et al. (2008) Histone Deacetylase Inhibitors Induce in Human Hepatoma HepG2 Cells Acetylation of p53 and Histones in Correlation with Apoptotic Effects. International Journal of Oncology, 32, 177-184. https://doi.org/10.3892/ijo.32.1.177
Chen, M.C., Chen, C.H., Chuang, H.C., et al. (2011) Novel Mechanism by Which Histone Deacetylase Inhibitors Facilitate Topoisomerase IIα Degradation in Hepatocellular Carcinoma Cells. Hepatology, 53, 148-159. https://doi.org/10.1002/hep.23964
Machado, M.C., Bellodi-Privato, M., Kubrusly, M.S., et al. (2011) Valproic Acid Inhibits Human Hepatocellular Cancer Cells Growth in Vitro and in Vivo. Journal of Experimental Therapeutics and Oncology, 9, 85-92.
Dykxhoorn, D.M., Chowdhury, D. and Ebem, J. (2008) RNA Interference and Cancer: Endogenous Pathways and Therapeutic Approaches. Advances in Experimental Medicine and Biology, 615, 299-329. https://doi.org/10.1007/978-1-4020-6554-5_14
Oliva, J., Bardag-Gorce, F., French, B.A., et al. (2009) The Regulation of Noncoding RNA Expression in the Liver of Mice Fed DDC. Experimental and Molecular Pathology, 87, 12-19. https://doi.org/10.1016/j.yexmp.2009.03.006
Wang, B., Hsu, S.H., Majumder, S., et al. (2010) TGFβ-Mediated Upregulation of Hepatic miR-181b Promotes Hepatocarcinogenesis by Targeting TIMP3. Oncogene, 29, 1787-1797. https://doi.org/10.1038/onc.2009.468
Beer, S., Bellovin, D.I., Lee, J.S., et al. (2010) Low-Level shRNA Cytotoxicity Can Contribute to MYC-Induced Hepatocellular Carcinoma in Adult Mice. Molecular Therapy, 18, 161-170. https://doi.org/10.1038/mt.2009.222